Bihar Covaxin trials on children begin at Patna's AIIMS
PATNA: Patna's All India Institute of Medical Sciences (AIIMS) has started the paediatric trials for the COVID-19 vaccine manufactured by the Bharat Biotech, Covaxin. Covaxin...
Centre books 30 cr doses of second made-in-India Covid vaccine from Hyderabad-based Biological-E
NEW DELHI: The health ministry has finalised arrangements with Hyderabad-based vaccine manufacturer Biological-E to book 30 crore COVID-19 vaccine doses, set to be manufactured...
Russia's single-dose Sputnik Light COVID-19 vaccine approved for use in Mauritius
MOSCOW: The Russian Direct Investment Fund (RDIF) on Wednesday announced the approval of the Russian single-dose Sputnik Light COVID-19 vaccine by the Mauritius Health...
Haffkine Bio-Pharma hopeful of Covaxin production in 8 months, targets 22.8 crore doses a year
MUMBAI: Haffkine Bio-Pharmaceutical Corporation Limited (HBPCL), a Maharashtra government undertaking, is preparing for mass production of Covaxin and will have capacity to produce over...
71% show faith in Covid vaccines
NEW DELHI: Amid a raging second wave of Covid-19 pandemic, over 71 per cent people in India have expressed faith in effectiveness of the...
Lucknow's Chhota Imambara to turn into vaccination centre
LUCKNOW: After the Eidgah in Aishbagh, it is now the historic Chhota Imambara in Lucknow that will be converted into a vaccination centre by...
Vidya Sethuraman India Post News Service Last week, the Food and Drug Administration (FDA) expanded its emergency use authorization for the Pfizer vaccine to include children...
1.84 crore vaccine doses still available with states, UTs
NEW DELHI: The Ministry of Health and Family Welfare on Thursday said more than 1.84 crore vaccine doses are still available with states and...
Pfizer tells Centre its vaccine suitable for 12 years and above
NEW DELHI: American pharmaceutical giant Pfizer on Wednesday informs the Central government that its COVID-19 vaccine is suitable for all aged 12 and above...
Health workers treat COVID19 patients at CWG Covid care center
NEW DELHI: With rise in the number of mucormycosis cases in the national capital, doctors have urged caution and said availability of drugs should...